🔎 Trials Near Me

Beranda › Makroglobulinemia Waldenstrom › New Jersey

Uji klinis Makroglobulinemia Waldenstrom di New Jersey

7 studi untuk Makroglobulinemia Waldenstrom mencari peserta di lokasi di New Jersey.

Kota di New Jersey

Teks studi resmi (Bahasa Inggris)

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memoral Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07231952

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04840602

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • Astera Cancer Care ( Site 2732), East Brunswick
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704), Hackensack
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04728893

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Rutgers Cancer Institute of New Jersey, New Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07101328

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • START New Jersey, East Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07424833

SynKIR-310 for Relapsed/Refractory B-NHL

  • Rutgers Cancer Institute, New Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT06544265

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Regional Cancer Care Associates, Hackensack
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT05544019

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.